^Fourneau E, Tréfouël J, Nitti F, Bovet D. Chimiothérapie de l'infection pneumococcique par la di-(p-acétylaminophényl)-sulfone (1399 F). Compt. Rend. Acad. Sci. July 1937, 205: 299 (法语).
^Fourneau JP. Ernest Fourneau, fondateur de la chimie thérapeutique française: feuillets d'album.. Revue d'Histoire de la Pharmacie. 1987, 75 (275): 335–55. doi:10.3406/pharm.1987.2904(法语).
^Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Leprosy Review. June 2003, 74 (2): 141–7. PMID 12862255. doi:10.47276/lr.74.2.141.
^Elslager EF, Gavrilis ZB, Phillips AA, Worth DF. Repository drugs. IV. 4',4'''-Sulfonylbisacetanilide (Acedapsone, DADDS) and related sulfanilylanilides with prolonged antimalarial and antileprotic action. Journal of Medicinal Chemistry. May 1969, 12 (3): 357–63. PMID 4892242. doi:10.1021/jm00303a003.
^Raiziss GW, Clemence LW, Severac M, Moetsch JC. Chemistry and Chemotherapy of 4,4′-Diaminodiphenylsulfone, 4-Amino-4′-hydroxy-diphenylsulfone and Related Compounds. Journal of the American Chemical Society. 1939, 61 (10): 2763–2765. doi:10.1021/ja01265a060.